Alternatives to Kova

The widest menu on our list — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, prices published for every plan length, and cancellation terms among the most restrictive we have read.

• $100 less per month on average than Kova
• serves all 50 states, where Kova lists Not published on the site
• offers FDA-approved brand pens, not just compounded

RxSpan MD is a genuinely well-disclosed service wrapped in marketing that undercuts it. The disclosure: four compounding pharmacies named with phone numbers, two lead physicians named with NPI numbers that verify as active MDs, flat pricing posted before any intake, both compounded and real FDA-approved brand GLP-1s on one platform, and oral capsules for anyone who won't inject. Compounded semaglutide is $249 a month and tirzepatide $329, with brand Zepbound at $1,069, Ozempic at $1,299 and Wegovy at $1,349. The marketing is the problem. Its testimonials still name a different company — one patient describes what she 'expected from CareGLP' — and the doctors quoted in them are not the clinicians the same page names as its medical team. The homepage is built around a board-certified plastic surgeon who founded the practice but is licensed in California only and isn't the prescriber. Its compounded prices also sit above the typical price we track, and the oral capsules cost the same or more than the injections.

• $50 less per month on average than Kova
• serves all 50 states, where Kova lists Not published on the site
• offers FDA-approved brand pens, not just compounded

Semaglutide: $199/mo; tirzepatide: Starting at $399/mo. Oral semaglutide starts at $299 and oral tirzepatide at $399; confirm your dose, plan length and cancellation terms.

• $100 less per month on average than Kova
• serves all 50 states, where Kova lists Not published on the site
• has an oral option if you would rather not inject

Pallas charges $199 every four weeks for compounded semaglutide and $299 for tirzepatide, after first-month offers of $139 and $179. Lower annual-plan averages require a longer commitment; provider care and shipping are included.

• $83.42 less per month on average than Kova
• serves all 50 states, where Kova lists Not published on the site
• offers FDA-approved brand pens, not just compounded

A menopause-focused program that bills insurance for eligible visits. The visit is covered in network or $250 self-pay, and the medication is billed separately from $164 per four-week supply — both figures published. It's built for perimenopause, not the postpartum year.

• $121.33 less per month on average than Kova
• serves all 50 states, where Kova lists Not published on the site
• offers FDA-approved brand pens, not just compounded

Three pages of this site quote three different prices for the same treatment: the homepage says semaglutide starts at $169 a month, the packages page shows $169 for month one and $199 from month two, and the semaglutide page says the program "typically ranges from $200-$550 per month" — a ceiling nothing on the site comes near. The packages page is the one to trust, and to its credit every plan total on it recomputes to the exact dollar. It also, on the oral semaglutide cards, tells you that what you will receive is tirzepatide.

• $100 less per month on average than Kova
• serves all 50 states, where Kova lists Not published on the site
• offers FDA-approved brand pens, not just compounded

Semaglutide: $249 every 4 weeks; $179 with 52 weeks prepaid; tirzepatide: $339 every 4 weeks; $269 with 52 weeks prepaid. Lower $179 and $269 amounts require 52 weeks prepaid, and the prices apply to four-week cycles.

• $29.25 less per month on average than Kova
• serves all 50 states, where Kova lists Not published on the site
• scores 61/100 against Kova's 35

An uncommon needle-free option — both semaglutide and tirzepatide sold as an oral tablet as well as an injection — with all-50-states coverage clearly disclosed, though its $179/mo semaglutide rate is explicitly a promo and its headline weight-loss stats are self-reported, not clinical.

• $50 less per month on average than Kova
• serves all 50 states, where Kova lists Not published on the site
• offers FDA-approved brand pens, not just compounded

The Edit advertises semaglutide at $200 for the first order, then $259 a month, and tirzepatide at $300 first order, then $349. Care, supplies and two-day temperature-controlled shipping are included; prepaid plans have separate totals.

• $40 less per month on average than Kova
• serves all 50 states, where Kova lists Not published on the site
• scores 62/100 against Kova's 35